{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:58:10Z","timestamp":1780775890795,"version":"3.54.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":2375,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-technology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Technology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1177\/2211068214564595","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T02:37:41Z","timestamp":1421203061000},"page":"562-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["An Overview on Prenatal Screening for Chromosomal Aberrations"],"prefix":"10.1016","volume":"20","author":[{"given":"Lucas","family":"Hixson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srishti","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Faltas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Narayakkadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/2211068214564595_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/1947-2714.109180","article-title":"Prenatal Screening Methods for Aneuploidies","volume":"5","author":"Dey","year":"2013","journal-title":"North Am. J. Med. Sci."},{"key":"10.1177\/2211068214564595_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tcb.2005.06.008","article-title":"Aneuploidy: A Matter of Bad Connections","volume":"15","author":"Cimini","year":"2005","journal-title":"Trends Cell Biol."},{"key":"10.1177\/2211068214564595_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/hmg\/ddm243","article-title":"The Origin of Human Aneuploidy: Where We Have Been, Where We Are Going","volume":"16","author":"Hassold","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1177\/2211068214564595_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1540-5826.2004.00097.x","article-title":"Turner Syndrome: Genetic and Hormonal Factors Contributing to a Speci\ufb01c Learning Disability Pro\ufb01le","volume":"19","author":"Rovette","year":"2004","journal-title":"Learn. Disabil. Res. Pract."},{"key":"10.1177\/2211068214564595_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/humupd\/4.6.842","article-title":"Chromosome Abnormalities in Human Embryos","volume":"4","author":"Munne","year":"1998","journal-title":"Hum. Reprod. Update"},{"key":"10.1177\/2211068214564595_bib6","unstructured":"Centers for Disease Control and Prevention. Key Findings: Prevalence of Down Syndrome in the United States. http:\/\/www.cdc.gov\/ncbddd\/birthdefects\/features\/key-findings-down-syndrome-prevalence.html"},{"key":"10.1177\/2211068214564595_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-7-81","article-title":"The Trisomy 18 Syndrome","volume":"7","author":"Cereda","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1177\/2211068214564595_bib8","unstructured":"American Accreditation HealthCare Commission. Trisomy 13\u2013Patau Syndrome. http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0002625\/"},{"key":"10.1177\/2211068214564595_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12041-009-0001-6","article-title":"Parental-Age Effects in Down Syndrome (Commentary on L.S. Penrose J. Genet)","volume":"88","author":"Girirajan","year":"2009","journal-title":"J. Genet."},{"key":"10.1177\/2211068214564595_bib10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM199208273270902","article-title":"Prenatal Screening for Down\u2019s Syndrome with Use of Maternal Serum Markers","volume":"327","author":"Haddow","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2211068214564595_bib11","unstructured":"American Accreditation HealthCare Commission. Karyo-typing. http:\/\/www.nlm.nih.gov\/medlineplus\/ency\/article\/003935.htm"},{"key":"10.1177\/2211068214564595_bib12","first-page":"423","article-title":"Prenatal Cytogenetic Diagnosis Study of 2782 Cases of High-Risk Pregnant Women","volume":"123","author":"Zhang","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1177\/2211068214564595_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000271995","article-title":"Update on Procedure-Related Risks for Prenatal Diagnosis Techniques","volume":"27","author":"Tabor","year":"2010","journal-title":"Fetal. Diagn. Ther."},{"key":"10.1177\/2211068214564595_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(05)79483-6","article-title":"CEMAT Grp Randomized Trial to Assess Safety and Fetal Outcome of Early and Mid-Trimester Amniocentesis","volume":"351","author":"Wilson","year":"1998","journal-title":"Lancet."},{"key":"10.1177\/2211068214564595_bib15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1056\/NEJM199208273270903","article-title":"A Randomized Comparison of Trans-Cervical and Trans-Abdominal Chorionic-Villus Sampling","volume":"327","author":"Jackson","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2211068214564595_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00274761","article-title":"Efficient Direct Chromosome Analyses and Enzyme Determinations from Chorionic Villi Samples in the 1st Trimester of Pregnancy","volume":"63","author":"Simoni","year":"1983","journal-title":"Hum. Genet."},{"key":"10.1177\/2211068214564595_bib17","first-page":"117","article-title":"Fetal Chromosomal Abnormalities: Antenatal Screening and Diagnosis","volume":"79","author":"Anderson","year":"2009","journal-title":"Am. Fam. Physician"},{"key":"10.1177\/2211068214564595_bib18","series-title":"Williams Obstetrics;","author":"Cunningham","year":"2005"},{"key":"10.1177\/2211068214564595_bib19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/GIM.0b013e3181bb267b","article-title":"Professional Practice Guidelines C Screening for Fetal Aneuploidy and Neural Tube Defects","volume":"11","author":"Driscoll","year":"2009","journal-title":"Genet. Med."},{"key":"10.1177\/2211068214564595_bib20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/pd.3961","article-title":"Integrated and First Trimester Prenatal Screening in California: Program Implementation and Patient Choice for Follow-up Services","volume":"32","author":"Currier","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1177\/2211068214564595_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10897-012-9545-3","article-title":"NSGC Practice Guideline: Prenatal Screening and Diagnostic Testing Options for Chromosome Aneuploidy","volume":"22","author":"Wilson","year":"2013","journal-title":"J. Genet. Counsel."},{"key":"10.1177\/2211068214564595_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1515\/cclm.2011.671","article-title":"Prenatal Screening for Trisomy 21: Recent Advances and Guidelines","volume":"50","author":"Canick","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1177\/2211068214564595_bib23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","article-title":"Society of Obstetricians and Gynaecologists of Canada Genetics Committee. Obstetrical Complications Associated with Abnormal Maternal Serum Markers Analytes","volume":"30","author":"Gagnon","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1177\/2211068214564595_bib24","unstructured":"Quest Diagnostics. Prenatal Screening and Diagnosis of Neural Tube Defects, Down Syndrome, and Trisomy 18. 2013. http:\/\/www.questdiagnostics.com\/testcenter\/testguide.action?dc=CFPrenatScreen"},{"key":"10.1177\/2211068214564595_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/clinchem\/30.4.538","article-title":"Measurement of Choriogonadotropin by Chemiluminescence Immunoassay and Immunochemiluminometric Assay: 1. Use of Isoluminol Derivatives","volume":"30","author":"Barnard","year":"1984","journal-title":"Clin Chem."},{"key":"10.1177\/2211068214564595_bib26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1373\/clinchem.2003.027797","article-title":"Comparison of Inhibin A Immunoassays: Recommendation for Adoption of Standardized Reporting","volume":"50","author":"Dighe","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1177\/2211068214564595_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/GIM.0b013e31815efde8","article-title":"First Trimester Diagnosis and Screening for Fetal Aneuploidy","volume":"10","author":"Driscoll","year":"2008","journal-title":"Genet. Med."},{"key":"10.1177\/2211068214564595_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/482832","article-title":"Analysis of Quality of Nuchal Translucency Measurements: Its Role in Prenatal Diagnosis","volume":"2012","author":"Gabriel","year":"2012","journal-title":"Sci. World J."},{"key":"10.1177\/2211068214564595_bib29","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/humrep\/15.9.2023","article-title":"Pregnancy Outcome and Infant Follow-up of Fetuses with Abnormally Increased First Trimester Nuchal Translucency","volume":"15","author":"Maymon","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1177\/2211068214564595_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/humupd\/dmg008","article-title":"Pathophysiology of Increased Nuchal Translucency: A Review of the Literature","volume":"9","author":"Haak","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"10.1177\/2211068214564595_bib31","first-page":"23","article-title":"Increased Nuchal Translucency in Normal Karyotype Fetuses","volume":"1","author":"De Domenico","year":"2011","journal-title":"J. Prenat. Med."},{"key":"10.1177\/2211068214564595_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/pd.413","article-title":"Increased Nuchal Translucency in Fetuses with a Normal Karyotype","volume":"22","author":"Hyett","year":"2002","journal-title":"Prenat. Diagn."},{"key":"10.1177\/2211068214564595_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1258\/jms.2010.009107","article-title":"Distribution of Nuchal Translucency in Antenatal Screening for Down\u2019s Syndrome","volume":"17","author":"Bestwick","year":"2010","journal-title":"J. Med. Screen."},{"key":"10.1177\/2211068214564595_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.12513","article-title":"Non-Invasive Prenatal Testing for Aneuploidy: Current Status and Future Prospects","volume":"42","author":"Benn","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1177\/2211068214564595_bib35","first-page":"873","article-title":"The Role of Fetal Karyotyping from Unconventional Sources","volume":"175","author":"Teoh","year":"1996","journal-title":"Obstet. Gynecol."},{"key":"10.1177\/2211068214564595_bib36","series-title":"Chromosomal Microarray Analysis (CMA) for Developmental Delay, Autism Spectrum Disorder, Intellectual Disability (Intellectual Developmental Disorder), and Congenital Anomalies;","year":"2014"},{"key":"10.1177\/2211068214564595_bib37","series-title":"Genetic Testing, Including Chromosomal Microarray (CMA) Analysis and Next Generation Sequencing Panels, for the Evaluation of Patients with Developmental Delay\/Intellectual Disability or Autism Spectrum Disorder;","year":"2014"},{"key":"10.1177\/2211068214564595_bib38","first-page":"1164","article-title":"Fluorescence In Situ Hybridization in Uncultured Amniocytes for Detection of Aneuploidy in 4210 Prenatal Cases","volume":"124","author":"Jia","year":"2011","journal-title":"Chin. Med. J."},{"key":"10.1177\/2211068214564595_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/pd.2946","article-title":"Same-Day Prenatal Diagnosis of Common Chromosomal Aneuploidies Using Microfluidics-Fluorescence In Situ Hybridization","volume":"32","author":"Ho","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1177\/2211068214564595_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0168-9525(91)90103-W","article-title":"Fluorescence In-Situ Hybridization-Applications in Cytogenetics and Gene-Mapping","volume":"7","author":"Trask","year":"1991","journal-title":"Trends Genet."},{"key":"10.1177\/2211068214564595_bib41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cll.2011.08.011","article-title":"Fluorescence In Situ Hybridization","volume":"31","author":"Tsuchiya","year":"2011","journal-title":"Clin. Lab. Med."},{"key":"10.1177\/2211068214564595_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/rep.0.1260279","article-title":"Rapid and Simple Prenatal Diagnosis of Common Chromosome Disorders: Advantages and Disadvantages of the Molecular Methods FISH and QF-PCR","volume":"126","author":"Hulten","year":"2003","journal-title":"Reproduction"},{"key":"10.1177\/2211068214564595_bib43","unstructured":"Image Solutions (UK) Ltd. Fast Prenatal Diagnosis with Automatic Interphase FISH Scanning. 2009. http:\/\/www.hospital-int.net\/article\/fast-prenatal-diagnosis-automatic-interphase-fish-scanning.html"},{"key":"10.1177\/2211068214564595_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/gte.2005.9.41","article-title":"Automatic Scanning of Interphase FISH for Prenatal Diagnosis in Uncultured Amniocytes","volume":"9","author":"Lev","year":"2005","journal-title":"Genet. Test."},{"key":"10.1177\/2211068214564595_bib45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/pd.1806","article-title":"Fully Automated FISH Examination of Amniotic Fluid Cells","volume":"27","author":"Wauters","year":"2007","journal-title":"Prenat. Diagn."},{"key":"10.1177\/2211068214564595_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ejhg.2008.161","article-title":"Rapid Aneuploidy Detection with Multiplex Ligation-Dependent Probe Amplification: A Prospective Study of 4000 Amniotic Fluid Samples","volume":"17","author":"Van Opstal","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1177\/2211068214564595_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/pd.2945","article-title":"QF-PCR: Application, Overview and Review of the Literature","volume":"32","author":"Mann","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1177\/2211068214564595_bib48","series-title":"ChromoQuant Version 2 QF PCR test. National Genetics Reference Laboratory (Wessex) ChromoQuant\u2122 (version 2) In Vitro Diagnostic Test Kit for Analysis of Common Chromosomal Disorders;","author":"White","year":"2005"},{"key":"10.1177\/2211068214564595_bib49","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/pd.1558","article-title":"Validation of QF-PCR for Prenatal Aneuploidy Screening in the United States","volume":"26","author":"Brown","year":"2006","journal-title":"Prenat. Diagn."},{"key":"10.1177\/2211068214564595_bib50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2353\/jmoldx.2010.090224","article-title":"Assessment of QF-PCR as the First Approach in Prenatal Diagnosis","volume":"12","author":"Badenas","year":"2010","journal-title":"J. Mol. Diagn."},{"key":"10.1177\/2211068214564595_bib51","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.fsigss.2007.10.193","article-title":"Rapid Prenatal Diagnosis of Common Chromosome Aneuploidies by QF-PCR: Evaluation of Two In Vitro Diagnostic Test Kits (Chromoquant and Aneufast)","volume":"1","author":"Turrina","year":"2008","journal-title":"Forensic Sci. Int. Genet. Suppl. Ser."},{"key":"10.1177\/2211068214564595_bib52","unstructured":"Anonymous QF-PCR Rapid Diagnosis of Trisomy 21, 18, 13 and Sex Chromosomes Aneuploidies. http:\/\/www.aneufast.com\/QF-PCR.html"},{"key":"10.1177\/2211068214564595_bib53","first-page":"2","article-title":"The Order of Nucleotides in a Gene Is Revealed by DNA Sequencing","volume":"4","author":"Chial","year":"2009","journal-title":"Essentials Genet."},{"key":"10.1177\/2211068214564595_bib54","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA Sequencing with Chain Terminating Inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1177\/2211068214564595_bib55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/321674a0","article-title":"Fluorescence Detection in Automated DNA sequence analysis","volume":"321","author":"Smith","year":"1986","journal-title":"Nature"},{"key":"10.1177\/2211068214564595_bib56","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.2443975","article-title":"A System for Rapid DNA Sequencing with Fluorescent Chain-Terminating Dideoxynucleotides","volume":"238","author":"Prober","year":"1987","journal-title":"Science"},{"key":"10.1177\/2211068214564595_bib57","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial Sequencing and Analysis of the Human Genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"10.1177\/2211068214564595_bib58","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The Sequence of the Human Genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"10.1177\/2211068214564595_bib59","doi-asserted-by":"crossref","first-page":"e38154","DOI":"10.1371\/journal.pone.0038154","article-title":"Noninvasive Prenatal Diagnosis of Fetal Trisomy 21 by Allelic Ratio Analysis Using Targeted Massively Parallel Sequencing of Maternal Plasma DNA","volume":"7","author":"Liao","year":"2012","journal-title":"PLoS One"},{"key":"10.1177\/2211068214564595_bib60","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1373\/clinchem.2010.144188","article-title":"Analysis of the Size Distributions of Fetal and Maternal Cell-Free DNA by Paired-End Sequencing","volume":"56","author":"Fan","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1177\/2211068214564595_bib61","doi-asserted-by":"crossref","first-page":"c7401","DOI":"10.1136\/bmj.c7401","article-title":"Non-Invasive Prenatal Assessment of Trisomy 21 by Multiplexed Maternal Plasma DNA Sequencing: Large Scale Validity Study","volume":"342","author":"Chiu","year":"2011","journal-title":"BMJ"},{"key":"10.1177\/2211068214564595_bib62","doi-asserted-by":"crossref","first-page":"e21791","DOI":"10.1371\/journal.pone.0021791","article-title":"Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1177\/2211068214564595_bib63","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive Prenatal Diagnosis of Fetal Chromosomal Aneuploidy by Massively Parallel Genomic Sequencing of DNA in Maternal Plasma","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1177\/2211068214564595_bib64","article-title":"Noninvasive Detection of Fetal Trisomy 21 by Sequencing of DNA in Maternal Blood: A Study in a Clinical Setting","volume":"204","author":"Ehrich","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1177\/2211068214564595_bib65","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive Diagnosis of Fetal Aneuploidy by Shotgun Sequencing DNA from Maternal Blood","volume":"105","author":"Fan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1177\/2211068214564595_bib66","article-title":"Noninvasive Prenatal Detection and Selective Analysis of Cell-Free DNA Obtained from Maternal Blood: Evaluation for Trisomy 21 and Trisomy 18","volume":"206","author":"Sparks","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1177\/2211068214564595_bib67","series-title":"DNA Sequencing and Equipment Markets","author":"Saeks","year":"2012"},{"key":"10.1177\/2211068214564595_bib68","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1755-0998.2011.03024.x","article-title":"Field Guide to Next-Generation DNA Sequencers","volume":"11","author":"Glenn","year":"2011","journal-title":"Mol. Ecol. Resources"},{"key":"10.1177\/2211068214564595_bib69","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature03959","article-title":"Genome Sequencing in Microfabricated High-Density Picoliter Reactors","volume":"437","author":"Margulies","year":"2005","journal-title":"Nature"},{"key":"10.1177\/2211068214564595_bib70","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1311037","article-title":"DNA Sequencing versus Standard Prenatal Aneuploidy Screening","volume":"370","author":"Bianchi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2211068214564595_bib71","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pd.4157","article-title":"Maternal cfDNA Screening for Down Syndrome\u2014A Cost Sensitivity Analysis","volume":"33","author":"Cuckle","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1177\/2211068214564595_bib72","series-title":"Molecular Diagnostics for Inherited Disease Testing","author":"Krul","year":"2004"},{"key":"10.1177\/2211068214564595_bib73","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3109\/14767058.2013.770464","article-title":"Clinical Utility and Cost of Non-Invasive Prenatal Testing with cfDNA Analysis in High-Risk Women Based on a US Population","volume":"26","author":"Song","year":"2013","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1177\/2211068214564595_bib74","unstructured":"California Department of Public Health. Genetic Disease Screening Program. 2011. http:\/\/www.cdph.ca.gov\/programs\/centerforfamilyhealth\/pages\/gdspfactsheet.aspx"},{"key":"10.1177\/2211068214564595_bib75","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.AOG.0000174581.24338.6f","article-title":"A Cost-Effectiveness Analysis of Prenatal Screening Strategies for Down syndrome","volume":"106","author":"Odibo","year":"2005","journal-title":"Obstet Gynecol."},{"key":"10.1177\/2211068214564595_bib76","unstructured":"American Pregnancy Association. Amniocentesis. 2006. http:\/\/americanpregnancy.org\/prenataltesting\/amniocentesis.html"},{"key":"10.1177\/2211068214564595_bib77","series-title":"The World Market for Molecular Diagnostics","author":"Rosen","year":"2013"},{"key":"10.1177\/2211068214564595_bib78","unstructured":"Martin A. Applied Biosystems Dominates the Real-Time PCR Market. 2003. http:\/\/www.prweb.com\/releases\/2003\/04\/prweb63940.htm"},{"key":"10.1177\/2211068214564595_bib79","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/1471-2164-13-341","article-title":"A Tale of Three Next Generation Sequencing Platforms\u2014Comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq Sequencers","volume":"13","author":"Quail","year":"2012","journal-title":"BMC Genomics"}],"container-title":["SLAS Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247263032201500X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247263032201500X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:01:58Z","timestamp":1762862518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247263032201500X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S247263032201500X"],"URL":"https:\/\/doi.org\/10.1177\/2211068214564595","relation":{},"ISSN":["2472-6303"],"issn-type":[{"value":"2472-6303","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Overview on Prenatal Screening for Chromosomal Aberrations","name":"articletitle","label":"Article Title"},{"value":"SLAS Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/2211068214564595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}